The Heart in Systemic Autoimmune Diseases 2nd Edition by Fabiola Atzeni 0444636690 9780444636690

The Heart in Systemic Autoimmune Diseases 2nd Edition by Fabiola Atzeni – Ebook PDF Instant Download/DeliveryISBN:  0444636690, 9780444636690 

Full download The Heart in Systemic Autoimmune Diseases 2nd Edition after payment.

Product details:

ISBN-10 ‏ : ‎0444636690 

ISBN-13 ‏ : ‎9780444636690

Author:   Fabiola Atzeni 

The Heart in Systemic Autoimmune Diseases, Second Edition, provides an overview on our current understanding of major complications relating to the heart and autoimmune diseases. It includes the latest information on the new pathogenetic mechanisms involved, along with clinical manifestations of these important comortbidities. Mortality in autoimmune diseases, in particular, rheumatoid arthritis and SLE, has increased when compared with the general population. This excess mortality is largely due to cardiovascular diseases (CVDs)-particularly those of atherosclerotic origin, such as ischemic heart disease-and is gaining recognition in all branches of medicine, from cardiology, to internal medicine, and from rheumatologists to orthopedics.

The Heart in Systemic Autoimmune Diseases 2nd Table of contents:

Chapter 1. Cellular Immunity: A Role for Cytokines
1. Introduction
2. Autoimmunity in Myocarditis
3. Pathogenesis: The Role of Cells and Cytokines
Chapter 2. Organ-Specific Autoimmunity Involvement in Cardiovascular Disease
1. Introduction
2. Post-Myocardial Infarction (Dressler) Syndrome
3. Post-Pericardiotomy Syndrome and Idiopathic Recurrent Acute Pericarditis
4. Rheumatic Carditis
5. Dilated Cardiomyopathy and Myocarditis
6. Idiopathic Tachy and Bradyarrhythmias
7. Systemic Arterial Hypertension
Chapter 3. Neonatal Lupus Syndromes: Pathogenesis and Clinical Features
1. Introduction
2. Epidemiology and Definition of Congenital Complete AVB
3. Etiology/Pathogenesis
4. Risk of Delivering a Child With Complete CHB
5. Clinical Manifestations
6. Treatment
7. Obstetric Management of Pregnancies at Risk of Developing CCHB
8. Prognosis
9. Other Pregnancy Outcomes in Women With Anti-Ro/SSA Antibodies
10. Anti-Ro/SSA Negative CHB
Chapter 4. Subclinical Cardiovascular Damage in Systemic Rheumatic Diseases
1. Introduction
2. Epidemiology and Role of Traditional Risk Factors
3. Subclinical Atherosclerosis
4. Cardiovascular Effects of Pharmacological Treatments
Chapter 5. Atherosclerosis and Autoimmunity
1. Introduction
2. Prevalence and Epidemiology
3. Pathogenesis
4. Clinical Manifestations
5. Diagnostic Investigations
6. Treatment
Chapter 6. Inflammasomes and Inflammatory Cytokines in Early Atherosclerosis
1. Introduction
2. Lipid Dysregulation in Autoimmunity
3. Innate Immunity and Inflammatory Signaling Mechanisms
4. Inflammasomes and IL-1β in Atherogenesis
5. β2-Glycoprotein I in Atherogenic Innate Immunity
6. Summary and Conclusions
Chapter 7. Treatment of Lipid Metabolism Disturbances in Autoimmune Diseases
1. Introduction
2. Lipid Metabolism Disturbances Relevant for Atherosclerosis and Cardiovascular Risk in Autoimmune Diseases
3. Serum Lipid Level Control in Autoimmune Diseases
4. Lipoprotein Function Modulation in Autoimmune Diseases
Chapter 8. Cardiac Imaging Techniques in Systemic Autoimmune Diseases
1. Introduction
2. Transthoracic Echocardiography
3. Transesophageal Echocardiography
4. Stress Echocardiography
5. Tissue Doppler Imaging
6. Speckle Tracking Echocardiography
7. Myocardial Contrast Echocardiography
8. Usefulness of Biomarkers of Endothelial Dysfunction
9. Carotid Ultrasonography
10. Conclusion
Chapter 9. New Cardiac Imaging Tools and Invasive Techniques in Systemic Autoimmune Diseases (Part II)
1. Introduction
2. Cardiac Magnetic Resonance Imaging
3. Computed Tomography
4. Right Heart Catheterization
5. Endomyocardial Biopsy
6. Conclusion
Chapter 10. Cardiac Diseases in Rheumatoid Arthritis
1. Introduction
2. Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis
3. Nonatherosclerotic Cardiovascular Disease
4. Conclusion
Chapter 11. Cardiac Involvement in Systemic Lupus Erythematosus
1. Introduction
2. Pericardial Involvement
3. Myocardial Involvement
4. Valvular Involvement
5. Coronary Artery Involvement
6. Conduction Tissue Involvement
7. Conclusions
Chapter 12. Cardiac Involvement in the Antiphospholipid Syndrome
1. Introduction
2. Epidemiology
3. Pathophysiology
4. Clinical Manifestations
5. Diagnostic Procedures
6. Differential Diagnosis
7. Treatment
8. Final Remarks
Chapter 13. Cardiac Involvement in Scleroderma
1. Introduction
2. Evidence for and Prognostic Impact of Clinical Cardiac Involvement
3. Prevalence of Subclinical Cardiac Involvement
4. Ischemic Heart Disease
5. Myocarditis
6. Hypertension
7. Arrhythmias
8. The Future
Chapter 14. Cardiac Involvement in Systemic Vasculitis
1. Introduction
2. Pathogenesis of Vasculitides
3. Cardiovascular Clinical Manifestations in Vasculitides
4. Evolution and Prognostic Factors
5. Treatment
6. Conclusions
Chapter 15. Cardiovascular Involvement in Ankylosing Spondylitis
1. Introduction
2. Cardiovascular Mortality in Ankylosing Spondylitis
3. Vascular Morbidity in Ankylosing Spondylitis
4. Cardiovascular Risk Factors in Ankylosing Spondylitis
5. Aortic Disease in Ankylosing Spondylitis
6. Mitral Valve Involvement in Ankylosing Spondylitis
7. Conduction Abnormalities in Ankylosing Spondylitis
8. Myocardium and Pericardium in Ankylosing Spondylitis
9. Subclinical Vascular Involvement in Ankylosing Spondylitis
10. Treatment and Its Implications in Atherosclerosis in Ankylosing Spondylitis
11. Conclusions
Chapter 16. Cardiovascular Involvement in Psoriatic Arthritis
1. Introduction
2. Epidemiology
3. Etiology/Pathogenesis
4. Clinical Manifestations
5. Diagnostic Investigations
6. Treatment
Chapter 17. Cardiovascular Involvement in Primary Sjögren’s Syndrome
1. Introduction
2. Raynaud Phenomenon
3. Cardiovascular Disease
4. Autonomic Cardiovascular Features
5. Pulmonary Arterial Hypertension
6. Arrhythmias
7. Pericarditis
8. Myocarditis
Chapter 18. Gout and Heart Disease: A Two-Way Street?
1. Introduction
2. Gout—Overview
3. Cardiovascular Disease
4. Gout and Traditional Cardiovascular Risk Factors
5. Etiology and Pathogenesis
6. Diagnostic Interventions
7. Treatment
8. Future Perspectives
9. Conclusion
Chapter 19. Heart Involvement in Osteoarthritis
1. Introduction
2. Prerequisites: Pathophysiology of Osteoarthritis
3. Epidemiologic Data: Osteoarthritis and Cardiovascular Diseases, Two Endemic Diseases
4. Association Between Osteoarthritis and Cardiovascular Diseases: Shared Risk Factors
5. Association Between Osteoarthritis and Cardiovascular Diseases: Direct Link Beyond CV Risk Factors
6. Association Between Osteoarthritis and Cardiovascular Diseases: an Epiphenomenon?
7. New Perspectives: The Role of Microbiota
8. Conclusions
Chapter 20. Cardiac Effects of Antirheumatic Drugs
1. Introduction
2. Atherosclerosis and Metabolic Syndrome
3. Other Heart Diseases
4. Recommendations for Cardiovascular Risk Management in Arthritides
5. Conclusions

People also search for The Heart in Systemic Autoimmune Diseases 2nd:

what autoimmune diseases affect the heart
    
how does autoimmune disease affect the heart
    
can autoimmune diseases affect the heart
    
autoimmune diseases heart
    
autoimmune disease heart symptoms

Tags: The Heart, Systemic, Autoimmune Diseases, Fabiola Atzeni